Nom du produit:3-Fluoropropanesulfonyl Chloride

IUPAC Name:3-fluoropropane-1-sulfonyl chloride

CAS:461-28-9
Formule moléculaire:C3H6ClFO2S
Pureté:95%+
Numéro de catalogue:CM386733
Poids moléculaire:160.59

Unité d'emballage Stock disponible Prix($) Quantité
CM386733-100mg in stock ưțư
CM386733-1g in stock ưƀǜ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:461-28-9
Formule moléculaire:C3H6ClFO2S
Point de fusion:-
Code SMILES:FCCCS(Cl)(=O)=O
Densité:
Numéro de catalogue:CM386733
Poids moléculaire:160.59
Point d'ébullition:
N° Mdl:
Stockage:

Column Infos

Tinlorafenib
The Journal of Medicinal Chemistry releases an article titled "Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer". Mutations in the BRAF gene result in MAPK pathway activation that are most commonly found in human melanomas. The BRAF V600E mutation is among the most frequent types. Present BRAF inhibitors have significantly improved treatment outcomes for patients with BRAF V600-mutant cancers. However, their effectiveness is limited by disease progression in the brain as they don’t adequately penetrate the blood-brain barrier (BBB).
Pfizer’s Tinlorafenib (formerly PF 07284890) is a highly brain-penetrant inhibitor of BRAF V600-mutant tumors, and currently in a phase 1 clinical trial (NCT04543188).